Caris Life Sciences (CAI) Interest & Investment Income (2024 - 2026)

Caris Life Sciences' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $6.8 million for Q1 2026.

• On a quarterly basis, Interest & Investment Income rose 1258.65% year-over-year to $6.8 million in Q1 2026; TTM through Mar 2026 was $22.8 million, a 289.74% increase from a year earlier, with the FY2025 full-year figure at $16.5 million, up 131.63% from the prior year.
• Interest & Investment Income eased to $6.8 million in Q1 2026 per CAI's latest filing, from $7.0 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $7.4 million in Q3 2025 and bottomed at $503000.0 in Q1 2025.
• The 3-year median for Interest & Investment Income is $2.2 million (2024), against an average of $3.6 million.
• Across the five-year window, Interest & Investment Income tumbled 38.71% in 2025 and soared 1258.65% in 2026, its largest moves.
• Year by year, Interest & Investment Income stood at $970000.0 in 2024, then jumped by 623.2% to $7.0 million in 2025, then decreased by 2.58% to $6.8 million in 2026.
• Per Business Quant, the three latest CAI Interest & Investment Income figures stand at $6.8 million (Q1 2026), $7.0 million (Q4 2025), and $7.4 million (Q3 2025).